A detailed history of Mcf Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Mcf Advisors LLC holds 188 shares of UTHR stock, worth $68,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188
Previous 188 -0.0%
Holding current value
$68,494
Previous $59,000 13.56%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

BUY
$166.16 - $213.96 $31,238 - $40,224
188 New
188 $33,000
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $34,652 - $40,623
-188 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$114.6 - $136.81 $21,544 - $25,720
188
188 $22,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.